Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lilly claims compounds for postmenopausal syndrome

Feb. 26, 1997

Hemosol's blood substitute advances to phase II

Feb. 25, 1997

Agents for infertility described by Novo Nordisk

Feb. 25, 1997

GH-releasing peptides from Novo Nordisk

Feb. 25, 1997

Novo Nordisk's growth hormone now available in 67 countries

Feb. 24, 1997

Merck's Fosamax earns recommendation

Feb. 24, 1997

SKB prepares chimeric leptins

Feb. 20, 1997

Indian investigators prepare novel hypolipidemic agents

Feb. 20, 1997

New ACAT inhibitor associated with diarrhea

Feb. 19, 1997

First launch for lipid-lowering statin

Feb. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.